Mark Cragg, PhD

Chair in Experimental Cancer Biology at University of Southampton

: Mark Cragg is Professor of Experimental Cancer Biology in the School of Cancer Sciences at the University of Southampton. His research concerns how therapeutics result in tumour regression with a focus on antibodies and small molecules, with a particular interest in Fc receptors and TNFR family members. The aim is to understand how these therapeutics delete tumour cells, how resistance occurs, and how it might be overcome.